×
Back to Agenda
Session 2: Statistical Session (Practical)
Session Chair(s)
David I. Raunig
Senior Vice President, Medical & Scientific Affairs, ICON, United States
This session will focus on practical application and case studies demonstrating implementation to include: current audit options (both published and non-published) and the advantages, disadvantages, challenges, and tactical pieces.
Speaker(s)
Ke Zhang, PhD
Director of Biostatistics, Pfizer, United States
Case Study: POLOMA-3 Trial
Na Xu, PhD
Senior Statistical Scientist, Genentech, A Member of the Roche Group, United States
A Case Study of PFS Audit Strategy in Metastatic Breast Cancer Patients
Panel Q&A
, United States
Have an account?